Anzeige
Mehr »
Donnerstag, 09.10.2025 - Börsentäglich über 12.000 News
Kursrakete 2025: CiTech präsentiert sich u.a. mit DroneShield neben Palantir & Rheinmetall - welche News sind zu erwarten?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQXP | ISIN: IL0011429839 | Ticker-Symbol: 5DT
Frankfurt
09.10.25 | 08:08
1,792 Euro
+12,85 % +0,204
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ENTERA BIO LTD Chart 1 Jahr
5-Tage-Chart
ENTERA BIO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,8641,98412:15
1,8641,98411:42

Aktuelle News zur ENTERA BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ENTERA BIO Aktie jetzt für 0€ handeln
25.09.Entera Bio stock rating reiterated at Buy by H.C. Wainwright2
18.09.Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy1
15.09.Entera Bio presents promising data for oral GLP-2 treatment for SBS3
11.09.Kudelski Group: NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace316Kudelski Group / Key word(s): Miscellaneous NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace 11.09.2025 / 07:00 CET/CEST New...
► Artikel lesen
10.09.Kudelski Group: NAGRAVISION Extends OneTV Solution at ONE Hungary, powered by OpenTV® ENTera to enable Third-Party Service Bundling with the Digital Vending Machine® from Bango323Kudelski Group / Key word(s): Miscellaneous NAGRAVISION Extends OneTV Solution at ONE Hungary, powered by OpenTV® ENTera to enable Third-Party Service Bundling with the Digital...
► Artikel lesen
08.09.Entera Bio Ltd.: Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 20251
11.08.Entera Bio GAAP EPS of -$0.06 beats by $0.103
08.08.Entera Bio Ltd. - 10-Q, Quarterly Report1
08.08.Entera Bio Ltd.: Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates156FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatmentSignificant...
► Artikel lesen
28.07.Entera Bio stock surges after FDA agrees on BMD endpoint for EB6131
28.07.Entera Bio: Aktie legt nach positivem FDA-Bescheid für Osteoporose-Studie deutlich zu5
28.07.FDA agrees to BMD endpoint for Entera's oral osteoporosis drug1
28.07.Entera Bio Ltd.: Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis 247JERUSALEM, July 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and protein replacement therapies, announced today that in a written response...
► Artikel lesen
28.07.Entera Bio Ltd. - 8-K, Current Report1
23.07.OPKO Health's (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX)5
18.07.Entera Bio: Aktionäre genehmigen Vorstandswahl und Vergütungsvorschläge1
18.07.Entera Bio Ltd. - 8-K, Current Report1
25.06.OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting338MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo...
► Artikel lesen
30.05.Entera Bio files $100M mixed securities shelf2
30.05.Entera Bio Ltd. - S-8, Securities to be offered to employees in employee benefit plans1
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1